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Local intravascnlar radiation therapy has shown 
promise in experimental nimals and in human pre- 
liminary studies for preventing restenosis after 
catheter-based interventions. However, higher sub- 
acute thrombosis rate and "edge effects" in 
brachytherapy and stent-based radiation therapy, 
respectively, have been reported. Therefore, it seems 
reasonable to review the published studies on the 
effect of external beam radiation on coronary disease 
and to compare these data with animal studies. 
Although radiation-induced coronary artery dis- 
ease occurs less fequently than typical coronary 
atherosclerosis, it  occurrence following external beam 
mediasth~al irradiation isno longer in doubt. The pre- 
cise incidence ofradiatiofi-induced accelerated athero- 
sclerosis is difficult to confirm secondary to the high 
prevalence of coronary artery disease in the Western 
population. The linkage of radiation arterial injury and 
subsequent a herosclerosis is strongest in yotmg indi- 
viduals who otherwise lack traditional risk factors for 
coronary atherosclerosis, particularly hyperlipidemia. 
Bovin et al 1 estimated the r lative risk of death from 
radiation-induced coronary artery disease as 1.5 
patients treated with mediastinal radiation with twice 
the number of deaths from coronary disease seen in 
the radiotherapy group with the cohort group. The 
incidence of radiation-induced coronary heart disease 
is greatest when radiation is given for Hodgkin's 
disease as compared with seminoma, breast carcinoma, 
lymphoma, and lung neoplasms. 2-4 
Pathology of radiation-induced heart disease 
Many of the pathologic hanges within the inti- 
rna, media, and adventitia secondary to radiation 
may be difficult to distinguish from typical athero- 
sclerotic oronary disease. Our experience is similar 
to that published by Brosius et al,5 in that the media 
is more severely destroyed and the adventitia is 
markedly thickened and fibrotic in radiation- 
induced coronary disease as compared with nonradi- 
ation-induced coronary therosclcrosis. 
Overall, the intimal plaque in radiation-induced 
arterial pathology is similar to common atherosclero- 
sis, although there is a trend toward greater lipid and 
calcium content and a decrease in fibrous tissue in 
radiated than in nonradiated atherosclerotic plaques. 5 
The disease varies from single vessel involvement toall 
four vessels involved by more than 75% cross-section- 
al area luminal narrowing. In the study by Brosius et 
al,5 at least 25% of the major coronary arteries were 
narrowed 75% to 100% in cross-sectional rea, an 
average of one of four major coronary arteries per 
patient. The proximal half of the right and left anteri- 
or descending coronary arteries in the radiated group 
was more often significantly narrowed than in the dis- 
tal portion of these arteries. 5 Intramyocardial coro- 
nary thickening was only seen in the radiated group 
and was most often seen in the right ventricle. ~
Endocardial thickening was also prominent and was 
observed in 75% of radiated patients with the highest 
frequency in the right ventricle. Similarly, valvular 
thickening was also common and occurred in over 
80% of patients with the tricuspid valve most fre- 
quently involved. ~Nearly all patients develop ericar- 
dial and epicardial fibrosis folloMng radiation with or 
without adhesions, and obliteration of the pericardial 
space is not unusual. The study by Brosius et al was 
published in 1981, and since that time, a greater 
understanding of the radiation injury to tissues has 
emerged with more attention paid to heart shielding. 
However, radiation-induced heart disease is still 
encountered; in our laboratory, we have seen recent 
cases in patients receiving radiation therapy for breast 
and lung malignancies. 
Pathology of  radiat ion- induced pigs coronary 
disease and rabbit iliac arteries after placement of  
[3-particle mitting stents 
We have recently reported our findings following 
placement of b-particle-emitting radioactive stents 
(0.15-23.0 ~tCi of 32P) in pig coronary arteries at 1 
and 6 months. We observed medial thinning and 
necrosis at 1 month in stents with more than 3 ~tCi 
radioactivity. The neointima mostly consisted of 
fibrin, red cells, and a few inflammatory cells. 
However, the lumen was significantly larger in radi- 
ated stented arteries than nonradiated control stents. 
At 1 ~tCi, the media was focally thinned, and the 
neointima consisted of smooth muscle cells in a 
matrix rich in proteoglycans with red cell accumula- 
tion around stent struts. In addition, there were 
greater numbers of neocapillarics around stent struts 
than in control nouradiated stented arteries, and the 
lumen was significantly smaller in the radiated group 
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than in the nonradiated controls. At less than 1 btCi, 
the pathologic hanges were very similar to those 
seen in controls except that the neointima was rich- 
er in proteoglycans and the lumen was larger in the 
radiated stent group. 6
32P beta-emitting radioactive stents were com- 
pared with control nonradiated Palmaz-Schatz stents 
that were placed in the porcine coronary arteries for 
6 months in a proliferative double injury model. 7 
Pigs were placed on a 2% cholesterol and 20% fat diet 
2 weeks before coronary artery balloon injury (1.2 to 
1.5 balloon to artery ratio) and were maintained on 
this diet for 4 weeks to create the intimal arterial 
plaque. Animals were then stented with a balloon- 
artery ratio of 1.1 and were fed a normal diet until 
euthanasia at 6 months. Each stent group (< 1 btCi, 
1 btCi, 3 btCi, 6 btCi, and 12 btCi) was compared with 
control nonradioactive stents. The morphologic 
changes varied with stent activity. At more than 3 
btCi, there was significantly greater luminal narrow- 
ing. The neointima contained focal areas of calcifica- 
tion and foam cell accumulation, and even well- 
developed necrotic cores were present. The lumen 
was significantly smaller than in control nonradiated 
stented arteries. The media was focally destroyed, 
and the adventitia was markedly thickened as com- 
pared with control nonradiated stented arteries. 
Other areas demonstrated a relatively hypocellular 
proteoglycan-rich thick neointima with smooth mus- 
cle cells localized toward the luminal surface. 
The morphologic hanges following placement 
of 1-gCi stents differed significantly from those seen 
at higher radiation doses. Arteries implanted with 1-
btCi radiated stents only occasionally showed 
macrophage collections, cholesterol clefts, and areas 
of calcification. However, the neointima was 
markedly increased as compared with control nonra- 
diated stented arteries. The neointima predominant- 
ly consisted of smooth muscle cells within a colla- 
gen/proteoglycan matrix. The smooth muscle cells 
were condensed toward the lumen where there was 
relatively little proteoglycan matrix. Areas close to 
the stent struts showed greater numbers of  neocap- 
illaries, but capillary density was less than high activ- 
ity stents and greater than control stents. The media 
was focally destroyed, and struts could often be seen 
in the adventitia with condensed collagen surround- 
ing the stent struts. At doses less than 1 btCi, there 
were no morphologic differences observed between 
radiated and control nonradiated arteries. 
Rabbit studies at 3 and 6 months following 
implantation of 32P radioactive stents in iliac arteries 
showed significant reduction in neointimal formation 
with 24 btCi. However, 6 btCi was only effective at 3 
months in inducing reduction of restenosis, and this 
benefidal effect was reversed at 6 months. The neoin- 
tima at 3 months in both doses was incompletely 
healed with greater fibrin deposition and fewer 
smooth muscle cells. There was incomplete ndothe- 
lialization at 3 months with both doses of  radioactive 
stents. However, at 6 months, although the 6-gCi 
stents showed complete coverage of the stent by 
endothelial cells, no such coverage was seen with 24 
gCi. Also, the nuclear cell proliferation was higher in 
the radiated arteries as compared with control at 3 
months. 
Comparison of  radiation-induced coronary artery 
disease in man and radiated stented porcine 
coronary arteries 
Despite the promising results in man from the 
various modalities of  vascular brachythcrapy, only a 
small number of patients have bccn treated to date, 
and a smaller number of studies at long term. We 
know from human external beam radiation studies 
that radiation-induced coronary disease takes at least 
5 years to develop. Also, animal studies have shown 
a delayed arterial healing after placement of  
radioactive stents and by brachytherapy. Thus, if 
the restenosis rate is 35% at 3 years following 
brachytherapy, it is likely to increase with another 
few years. Anecdotally, we have observed elayed 
late in-stent coronary thrombosis associated with 
delayed healing 2 months after treatment with 
32P-impregnated wire (28 Gy targeted to a depth 
of 0.5 ram). 
Radiation-induced coronary disease in man 
results in luminal narrowing that is mostly limited to 
the proximal portions of the arterial tree. The mor- 
phologic changes are different from typical athero- 
sclerosis with more frequent medial destruction and 
greater adventitial fibrosis and thickening produced 
postradiation. These pathologic findings are similar 
to the late changes (6 months) seen in radiated 
stented porcine arteries and rabbit iliac arteries con- 
sisting of areas of necrosis, foam cell deposition, and 
calcification that were only observed in the radiated 
stents along with adventitial thickening and medial 
thinning. These data on the negative ffects of  radi- 
ation indicate that further study of  the use of radia- 
tion as a potential therapy for vascular disease postin- 
tervention is warranted before wide application of 
this novel treatment is adopted. 
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Thrombosis on the substrate of  a disrupted 
atheromatous plaque causes most acute coronary 
events. The physical integrity of the plaque, notably 
of  the extracellular matrix of  the fibrous capsule 
overlying the atheroma's thrombogenic lipid core, 
thus governs the most important clinical manifesta- 
tions of  atherosclerosis. Stable atheroma generally 
has thick fibrous caps and lipid pools smaller than 
lesions that have ruptured. Accumulating evidence 
supports akey role for inflammation as another crit- 
ical determinant of  the stability of  human athero- 
sclerotic plaques. Plaques that rupture generally 
have more abundant leukocytic infiltrates than 
those considered stable. Inflammatory mediators 
such as cytokines can influence several biological 
processes that regulate stability of  the plaque's 
fibrous cap, hence its resistance to rupture. For 
example, gamma interferon, produced by activated 
T lymphocytes within atheroma inhibits the pro- 
duction of interstitial forms of collagen by human 
vascular smooth muscle cells. Inf lammatory 
cytoldnes uch as interleukin-1, tumor necrosis fac- 
tor (TNF), and the cell surface homolog of TNF-a 
known as CD-40 ligand can also elicit the expres- 
sion by macrophages and smooth muscle cells of  
enzymes that can weaken the xtracellular matrix. 
Foam cells derived from both macrophages and 
smooth muscles also express active matrix-degrad- 
ing enzymes. We have hypothesized that lipid low- 
ering reduces timuli for the inflammatory response 
within the complicated atherosclerotic lesion. 
Classical studies in nonhuman primates uggested 
that lipid lowering produces qualitative changes in 
plaques more complex than mere "regression." 
Recent data from experimental studies in rabbits 
indicate that lipid lowering can reduce inflamma- 
tion in the atheroma, monitoring modern markers 
of vascular cell functions related to atheroma stabil- 
ity. In particular, lipid lowering by diet can reduce 
the number of  macrophages in plaques, and their 
expression of  such mediators of  plaque instability 
such as collagen-degrading matrix metallopro- 
teinases. Moreover, the collagen content of plaques 
increases during chronic lipid lowering, rendering 
plaques less friable and more resistant o rupture. 
After lipid-lowering smooth muscle cells in the 
plaque exhibit a more mature phenotype, using the 
expression of myosin isoforms as a molecular mark- 
cr. Macrophages and smooth muscle cells within 
plaques have reduced expression of  the potent pro- 
coagulant, tissue factor, a major instigator of  
thrombosis on disrupted atherosclerotic plaques. 
Such observations provide a mechanistic basis for 
understanding the marked reduction in acute coro- 
nary events observed in patients treated with agents 
that reduce their serum cholesterol levels. 
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Imaging techniques currently used to identify 
preclirdcal atherosclerotic lesions include measure- 
ment of carotid intima-media thickness (IMT) with 
B-mode ultrasound, coronary calcium scoring using 
electron beam computerized tomography (EBCT) 
or ultra-fast helical CT, endothelial function studies 
using B-mode ultrasound, and magnetic resonance 
imaging (MRI) of  the arterial wall. 1-6 With the 
exception of EBCT, each of  these technologies i
widely available in the clinical as well as the research 
setting. 
It is accepted that individuals with established 
coronary heart disease (CHD) benefit from aggres- 
sive medical intervention. Such intervention, termed 
secondary prevention, is directed at reducing mor- 
bidity and mortality in individuals at risk for recur- 
rent events. In contrast, primary prevention focuses 
